Skip to main content
Publications

Securities Class Actions in the Life Sciences Sector

Spring 2025
Authors
Sara B. BrodySarah A. HemmendingerFrancesca E. BrodyRobin E. Wechkin

Sidley is pleased to present its annual review addressing developments in securities class actions brought against life sciences companies in 2024.

In this publication, we begin with an overview and analysis of trends in federal district court and appellate decisions in these cases. We then provide summaries of the 49 decisions surveyed. Finally, we catalog the new securities class action complaints filed against life sciences companies in 2024.

Click here to download the PDF.
Click here to view a two-page summary.
Click here to order hard copies. Limited supply available.

Knowledge Management Lawyer Zarine Alam also contributed to the 2024 annual report.

Contacts

Brody, Sara B.
合伙人律师
Hemmendinger, Sarah A.
合伙人律师
Brody, Francesca E.
合伙人律师
Wechkin, Robin E.
资深顾问律师
西雅图
+1 415 439 1799

Capabilities

Suggested News & Insights

Bay Area Life Sciences RoundtableWednesday, July 22, 2026
活动
Sidley Sponsors the 2026 EU Pharma Law ForumTuesday, May 19, 2026 – Thursday, May 21, 2026
活动
Women’s Life Sciences Network – Biotech Act: Funding and Investment OpportunitiesTuesday, May 19, 2026
活动
Growth Meets Guardrails: Getting You Ready for the New Realm of Ad/PromoWednesday, May 13, 2026
活动
Global Trial Expansion — Key Considerations for EU/U.S. SponsorsApril 21, 2026
活动
U.S. FDA Issues First Drug Supply Chain Security Act Warning Letter Targeting a Dispenser, Signaling Expanded Enforcement FocusApril 15, 2026
Food, Drug, and Medical Device Update